First Time Loading...

Dechra Pharmaceuticals PLC
LSE:DPH

Watchlist Manager
Dechra Pharmaceuticals PLC Logo
Dechra Pharmaceuticals PLC
LSE:DPH
Watchlist
Price: 3 866 GBX Market Closed
Updated: May 10, 2024

Dechra Pharmaceuticals PLC
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Dechra Pharmaceuticals PLC
Net Income (Common) Peer Comparison

Comparables:
GSK
AZN
VRNA
INDV
HIK

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Dechra Pharmaceuticals PLC
LSE:DPH
Net Income (Common)
-£27.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
GlaxoSmithKline PLC
LSE:GSK
Net Income (Common)
£4.5B
CAGR 3-Years
-5%
CAGR 5-Years
3%
CAGR 10-Years
-1%
AstraZeneca PLC
LSE:AZN
Net Income (Common)
$6.3B
CAGR 3-Years
17%
CAGR 5-Years
21%
CAGR 10-Years
12%
Verona Pharma PLC
NASDAQ:VRNA
Net Income (Common)
-$54.4m
CAGR 3-Years
6%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Indivior PLC
LSE:INDV
Net Income (Common)
$5m
CAGR 3-Years
-63%
CAGR 5-Years
-54%
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Net Income (Common)
$190m
CAGR 3-Years
-24%
CAGR 5-Years
-8%
CAGR 10-Years
-1%

See Also

What is Dechra Pharmaceuticals PLC's Net Income (Common)?
Net Income (Common)
-27.9m GBP

Based on the financial report for Jun 30, 2023, Dechra Pharmaceuticals PLC's Net Income (Common) amounts to -27.9m GBP.